Angiogenic switch occurs late in squamous cell carcinomas of human skin

Angiogenesis is a crucial event in carcinogenesis and its onset has been associated with premalignant tumour stages. In order to elucidate the significance of angiogenesis in different stages of epithelial skin tumours, we analysed the vessel density in ten normal skin samples, 14 actinic keratosis (AK), 12 hypertrophic AKs, and in nine early- and 16 late-stage squamous cell carcinomas (SCCs). Mean vascular density was quantitated by counting the number of CD 31-immunostained blood vessels and by morphometric assessment of stained vessel area by computer-assisted image analysis. The results from both methods were well correlated. Mean vascular density was similar in normal dermis and in AK, and only slightly elevated in hypertrophic AKs and early SCC stages (tumour thickness < 2 mm). Only late-stage SCCs infiltrating the subcutis exhibited a significant increase in vascularization. Vessel density was independent of tumour localization, degree of proliferation and inflammatory cell infiltration. Furthermore, tumour vascularization was not correlated with the expression of vascular endothelial growth factor, a major angiogenic factor, as revealed by in situ hybridization and immunohistochemistry. The restriction of enhanced vascularization to increased tumour thickness may be a major reason for the rather low metastatic spread of cutaneous SCCs. © 2000 Cancer Research Campaign

[1]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[2]  Claudio Eccher,et al.  Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computer-aided image analysis system , 1995 .

[3]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[4]  J. Medina,et al.  Perineural invasion in squamous cell skin carcinoma of the head and neck. , 1984, American journal of surgery.

[5]  C. Ballaun,et al.  Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[6]  G. Rennie,et al.  MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA , 1988, The Lancet.

[7]  G. Rassner,et al.  Microstaging of squamous cell carcinomas. , 1990, American journal of clinical pathology.

[8]  D. Hanahan,et al.  Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. , 1996, The American journal of pathology.

[9]  Jordi Graells,et al.  Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase , 1997, Journal of cutaneous pathology.

[10]  P. Leboit,et al.  p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. , 1994, Archives of dermatology.

[11]  M C Mihm,et al.  Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[12]  R. Kerbel,et al.  Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. , 1996, European journal of cancer.

[13]  E. Tschachler,et al.  Differences in tumor microvessel density between squamous cell carcinomas and basal cell carcinomas may relate to their different biologic behavior , 1997, Journal of cutaneous pathology.

[14]  N. Weidner,et al.  Intratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinoma , 1993, International journal of cancer.

[15]  K. Smith-McCune,et al.  Demonstration and characterization of the angiogenic properties of cervical dysplasia. , 1994, Cancer research.

[16]  S. Tahan,et al.  Angiogenesis in invasive squamous cell carcinoma of the lip: tumor vascularity is not an indicator of metastatic risk , 1995, Journal of cutaneous pathology.

[17]  G. Nicolson,et al.  Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. , 1992, British Journal of Cancer.

[18]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[19]  D. Connolly,et al.  Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.

[20]  N. Fusenig,et al.  Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss. , 1995, Oncogene.

[21]  D. Hanahan,et al.  Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. , 1997, Cancer research.

[22]  H. Dvorak,et al.  Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing , 1992, The Journal of experimental medicine.

[23]  S. Hsu,et al.  Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. , 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[24]  M. Mitze,et al.  Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma. , 1995, Gynecologic oncology.

[25]  H. Dvorak,et al.  Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. , 1995, The Journal of investigative dermatology.

[26]  A. Howell,et al.  Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. , 1993, European journal of cancer.

[27]  N. Fusenig,et al.  Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes , 1998, Molecular carcinogenesis.

[28]  Mihaela Skobe,et al.  Halting angiogenesis suppresses carcinoma cell invasion , 1997, Nature Medicine.

[29]  F. Urbach,et al.  Anatomy of Human Skin Tumour Capillaries , 1962, Nature.

[30]  A. Srivastava,et al.  The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. , 1988, The American journal of pathology.

[31]  R. Willén,et al.  Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck , 1995, Head & neck.

[32]  S. Fox,et al.  Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. , 1996, European journal of cancer.

[33]  C. Snyderman,et al.  Tumor angiogenesis as a predictor of tumor aggressiveness and metastatic potential in squamous cell carcinoma of the head and neck. , 1995, Invasion & metastasis.

[34]  H. Dvorak,et al.  Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. , 1997, The Journal of investigative dermatology.

[35]  R. Barnhill,et al.  Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis. , 1993, The American journal of pathology.

[36]  N. Weidner Intratumor microvessel density as a prognostic factor in cancer. , 1995, The American journal of pathology.

[37]  G. de Rosa,et al.  The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. , 1996, Human pathology.

[38]  H. Dvorak,et al.  Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis , 1994, The Journal of experimental medicine.

[39]  T. Jacks,et al.  Sunburn and p53 in the onset of skin cancer , 1994, Nature.

[40]  R. Kerbel,et al.  Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas. , 1994, The American journal of pathology.

[41]  Anthony J. Guidi,et al.  Microvessel density and distribution in ductal carcinoma in situ of the breast. , 1994, Journal of the National Cancer Institute.

[42]  K. Danø,et al.  The Plasminogen Activation System in Human Colon Cancer : Messenger RNA for the Inhibitor PAI-1 Is Located in Endothelial Cells in the Tumor , 2006 .